Payman Khales has officially taken over as President and CEO of Integer Holdings Corporation, a leading global medical device contract development and manufacturing organization. This transition was part of a planned succession, with Khales assuming the role from Joseph Dziedzic, who served as President and CEO for eight years. Khales, who joined Integer in 2018, has demonstrated his capabilities by doubling sales in the Cardio & Vascular business over seven years and driving above-market growth. As Chief Operating Officer, he further strengthened Integer's reputation as a strategic partner to medical device companies and OEMs worldwide.
Under Khales' leadership, Integer looks poised to continue its growth trajectory. The company's focus on innovation, collaboration with customers, and delivering life-changing medical technologies to patients around the world is expected to create value in the coming years. Khales' experience in senior leadership roles at CECO Environmental Corp. and Ingersoll Rand Company, combined with his educational background, positions him well to lead Integer into its next phase of development.
Integer Holdings Corporation, with brands including Greatbatch Medical® and Lake Region Medical®, is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. As a strategic partner to medical device companies and OEMs, Integer's focus on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets is expected to continue under Khales' leadership. Following these announcements, the company's shares moved -32.28%, and are now trading at a price of $73.89. Check out the company's full 8-K submission here.
